Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kiyoharu Takikawa is active.

Publication


Featured researches published by Kiyoharu Takikawa.


American Heart Journal | 1978

Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade

Kyuzo Aoki; Shuta Kondo; Akihiro Mochizuki; Tadashi Yoshida; Setsuko Kato; Kazuaki Kato; Kiyoharu Takikawa

Abstract The effect of the administration of a cardiovascular Ca2+-antagonist (nifedipine) on arterial blood pressure, heart rate, and plasma renin activity was investigated. Blood pressure of normotensive healthy volunteers (n = 4) does not change significantly by administration of 10 mg. (from 119 78 to 120 75 mm. Hg ) and 30 mg. (from 114 69 to 105 66 mm. Hg ) of nifedipine. When nifedipine (30 mg.) is administered with propranolol (beta-blockade), a slight decrease of systolic and diastolic blood pressure was observed (from 119 73 to 104 67 mm. Hg ). Blood pressure of hypertensive patients is significantly lowered by 10 mg. of nifedipine from 172.9 to 130.3 mm. Hg (25 per cent reduction) systolic, and from 112.9 to 86.6 mm. Hg (23 per cent) diastolic (n = 7). Thirty mg. nifedipine had a slightly stronger hypotensive effect, namely 27 per cent reduction in systolic and 28 per cent in diastolic values (n = 9). Combined administration of nifedipine and propranolol, resulted in lowering initial blood pressure by 32 per cent and 30 per cent reduction in systolic and diastolic (n = 8), respectively. The heart rate of normotensive patients hardly changes with administration of 10 and 30 mg. of nifedipine and combined medication. But in hypertensive subjects it is significantly increased by nifedipine; from 66.3 to 80.3 (p Plasma renin activity of normotensive and hypertensive subjects is increased by 30 mg. of nifedipine. Combined administration of nifedipine and propranolol decreases plasma renin activity in both normotensive and hypertensive patients. The antihypertensive effect of nifedipine is enhanced and prolonged by propranolol. The observed increase in heart rate and plasma renin activity with nifedipine is inhibited by propranolol, probably by inhibiting the cardiovascular effects of the activity of the sympathetic nervous system. The results of this study indicate that oral administration of nifedipine is very effective in lowering arterial blood pressure in hypertensive patients, especially when combined with propranolol. Administration of nifedipine with beta-blockade resulted in satisfactory management of hypertension with minimal adverse drug reactions which could be possibly attributed to the preparation, especially in the management of hypertensive emergencies including hypertension associated with acute myocardial infarction and coronary insufficiency.


Japanese Heart Journal | 1976

Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients.

Kyuzo Aoki; Tadashi Yoshida; Setsuko Kato; Kazuhiro Tazumi; Iwao Sato; Kiyoharu Takikawa; Ken Hotta


Nature | 1973

Role of adrenal cortex and medulla in hypertension.

Kyuzo Aoki; Kiyoharu Takikawa; Ken Hotta


Japanese Circulation Journal-english Edition | 1975

SERUM DOPAMINE-β-HYDROXYLASE ACTIVITY IN ESSENTIAL HYPERTENSION AND IN CHRONIC RENAL FAILURE WITH HYPERTENSION

Kyuzo Aoki; Kazuhiro Tazumi; Kiyoharu Takikawa


Japanese Circulation Journal-english Edition | 1976

Calcium uptake, release and Mg-ATPase activity of sarcoplasmic reticulum from arterial smooth muscle.

Kanae Yamashita; Kyuzo Aoki; Kiyoharu Takikawa; Ken Hotta


Japanese Circulation Journal-english Edition | 1974

VASCULAR SMOOTH MUSCLE CONTRACTION IN HYPERTENSION : PROCEEDINGS OF THE 38TH ANNUAL MEETING OF THE JAPANESE CIRCULATION SOCIETY

Kyuzo Aoki; Kanae Yamashita; Nobuko Tomita; Kazuhiro Tazumi; Sesuko Kato; Tadashi Yoshida; Shimazaki H; Iwao Sato; Kiyoharu Takikawa; Ken Hotta


Clinical Science | 1976

Serum dopamine beta-hydroxylase activity in essential hypertension.

Kyuzo Aoki; Kazuhiro Tazumi; Tadashi Yoshida; Setsuko Kato; Iwao Sato; Kiyoharu Takikawa


Japanese Heart Journal | 1973

Hypertension Persisted Following Bilateral Adrenal Medullectomy

Kyuzo Aoki; Kazuhiro Tazumi; Iwao Sato; Yoshimi Kobayashi; Kiyoharu Takikawa; Ken Hotta


Japanese Heart Journal | 1973

The Spontaneously Hypertensive Rat (SHR)

Tetsuya Inatome; Yutaka Furuta; Susumu Yorifuji; Akinobu Nagaoka; Hisashi Iwatsuka; Ziro Suzuoki; Kozo Okamoto; Kiro Shimamoto; Akio Teraoka; Kioko Kawai; Hideo Tsuchiyama; Hajime Sugihara; Yukio Yamori; Akira Ooshima; Yasuyuki Morotomi; Kenjiro Tanaka; Teruo Omae; Kumiko Shiono; Hirofumi Sokabe; Nagao Kajiwara; Yoshiko Kobayashi; Akira Murakami; Jun Hashida; Takahisa Uchiyama; Takashi Kita; Masahiko Sato; Yoshihide Okumura; Masashi Ono; Takeshi Mikami; Kenzo Oshima


Japanese Circulation Journal-english Edition | 1973

ADRENAL CORTEX, NO MEDULLA, CONTRIBUTING TO PERSIST HYPERTENSION : (Part II)

Kyuzo Aoki; Kazuhiro Tazumi; Iwao Sato; Kiyoharu Takikawa; Ken Hotta

Collaboration


Dive into the Kiyoharu Takikawa's collaboration.

Top Co-Authors

Avatar

Kyuzo Aoki

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ken Hotta

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar

Iwao Sato

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akinobu Nagaoka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akio Teraoka

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge